parenteral nutrition

TORONTO, ON, Canada – May 5, 2026 Takeda Canada Inc. has announced that REVESTIVE® (teduglutide for injection) will now...

WESTON, FLORIDA, April 27, 2026 Apotex has secured U.S. Food and Drug Administration (FDA) approval for its generic Infuvite®...

WESTON, FLORIDA, USA, April 14, 2026 Apotex Corp., in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma...